Bovine viral diarrhea virus with deletions in the 5′-nontranslated region: Reduction of replication in calves and induction of protective immunity

Vaccine

Volumn 22, Issue 25-26, 2004, Pages 3285-3294

  Makoschey, B ^a   Becher, P ^b   Janssen, M G J ^a   Orlich, M ^b   Thiel, H J ^b   Lutticken D ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

5 NTR; Bovine viral diarrhea virus; Cattle; deletion mutants of bovine viral diarrhea virus as vaccine; Vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS VACCINE;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; ATTENUATION; BOVINE DIARRHEA VIRUS; CATTLE; CONTROLLED STUDY; DELETION MUTANT; DRUG EFFICACY; FEVER; GENETIC STABILITY; IMMUNITY; INOCULATION; LEUKOCYTE COUNT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIREMIA; VIRUS CULTURE; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

5' UNTRANSLATED REGIONS; ANIMALS; BLOTTING, NORTHERN; BODY TEMPERATURE; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CATTLE DISEASES; DIARRHEA VIRUSES, BOVINE VIRAL; ERYTHROCYTES; KINETICS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MUTATION; NEUTRALIZATION TESTS; PHENOTYPE; PLAQUE ASSAY; RNA, VIRAL; VACCINES, ATTENUATED; VIRAL VACCINES; VIREMIA; VIRUS REPLICATION;

EID: 4043092128     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.003     Document Type: Article

References (43)

1. Heinz FX, Collett MS, Purcell RH, Gould EA, Howard CR, Houghton M, et al. Family Flaviviridae. In: van Regenmortel MHV, Fauquet CM, Bishop DHL, et al., editors. Virus taxonomy, seventh report of the International Committee on Taxonomy of Viruses. San Diego: Academic Press; 2000. p. 859-78.
2. Childs T. X disease of cattle. Can J Comp Med Vet Sci. 10:1946;316-319
3. Olafson P., MacCallum A.D., Fox F.H. An apparently new transmissible disease of cattle. Cornell Vet. 36:1946;205-213
4. Thomas L.H., Stott E.J., Collins A.P., Jebbet N.J., Stark A.J. Evaluation of respiratory disease in calves: comparison of disease response to different viruses. Res. Vet. Sci. 23:1977;157-164
5. Potgieter L.N.D., McCracken M.D., Hopkins F.M., Guy J.S. Comparison of pneumopathogenicity of two strains of bovine viral diarrhea virus. Am. J. Vet Res. 46:1985;151-153
6. Howard C.J., Clarke M.C., Sopp P., Brownlie J. Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet Microbiol. 42:1994;171-179
7. Rebhun W.C., French T.W., Perdrizet J.A., Dubovi E., Dill S.G., Karcher L.F. Thrombocytopenia associated with acute bovine virus diarrhea infection in cattle. J. Vet. Intern. Med. 3:1989;42-46
8. Corapi W.V., French T.W., Dubovi E. Severe thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. J. Virol. 63:1989;3934-3943
9. Moennig V., Liess B. Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet Clin N Am Food Anim. Pract. 11:1995;477-487
10. Bolin S.R. The pathogenesis of mucosal disease. Vet Clin N Am Food Anim. Pract. 11:1995;489-500
11. Houe H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol. 64:1999;89-107
12. Houe H. Economic impact of BVDV infection in dairies. Biologicals. 31:2003;137-143
13. Bitsch V., Ronsholt L. Control of bovine viral diarrhea virus infection without vaccines. Vet Clin N Am Food Anim. Pract. 11:1995;627-640
14. Lindberg A.L., Alenius S. Principles for eradication of bovine viral diarrhoea virus (BVDV) infections in cattle populations. Vet Microbiol. 64:1999;197-222
15. Grom J., Barlic-Maganja D. Bovine viral diarrhoea (BVD) infections-control and eradication programme in breeding herds in Slovenia. Vet Microbiol. 64:1999;259-264
16. Synge B.A., Clark A.M., Moar J.A., Nicolson J.T., Nettleton P.F., Herring J.A. The control of bovine virus diarrhoea virus in Shetland. Vet Microbiol. 64:1999;223-229
17. van Oirschot J.T., Bruschke C.J., van Rijn P.A. Vaccination of cattle against bovine viral diarrhoea. Vet. Microbiol. 64:1999;169-183
18. Greiser-Wilke I., Grummer B., Moennig V. Bovine viral diarrhoea eradication and control programmes in Europe. Biologicals. 31:2003;113-118
19. Patel J.R., Shilleto R.W., Williams J., Alexander D.C. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination. Arch Virol. 147:2002;2453-2463
20. Brownlie J., Clarke M.C., Hooper L.B., Bell G.D. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet. Rec. 137:1995;58-62
21. Frey H.R., Eicken K., Grummer B., Kenklies S., Oguzoglu T.C., Moennig V. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. J. Vet. Med. B. 49:2002;489-493
22. Bolin S.R. Control of bovine viral diarrhea infection by use of vaccination. Vet Clin N Am Food Anim. Pract. 11:1995;615-625
23. Orban S., Liess B., Hafez S.M., Frey H.-R., Blindow H., Sasse-Pantzer B. Studies on transplacental transmissibility of a bovine viral diarrhoea (BVD) vaccine virus. I. Inoculation of pregnant cows 15 to 90 days before parturition (190th to 265th day of gestation). Zentralbl Veterinärmed B. 30:1983;619-634
24. Liess B., Orban S., Frey H.-R., Trautwein G., Wiefel W., Blindow H. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation. Zentralbl Veterinärmed B. 31:1984;669-681
25. Becher P., Orlich M., Thiel H.-J. RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease. J. Virol. 75:2001;6256-6264
26. Becher P., Orlich M., Thiel H.-J. Mutations in the 5′ nontranslated region of bovine viral diarrhea virus result in altered growth characteristics. J. Virol. 74:2000;7884-7894
27. Avalos-Ramirez R., Orlich M., Thiel H.-J., Becher P. Evidence for the presence of two novel pestivirus species. Virology. 286:2001;456-465
28. Becher P., Orlich M., Thiel H.-J. Complete genomic sequence of border disease virus, a pestivirus from sheep. J. Virol. 72:1998;5165-5173
29. Makoschey B., Janssen M.G.J., Vrijenhoek M.P., Korsten J.H.M., Van der Marel P. An inactivated bovine virus diarrhoea virus (BVDV) type1 vaccine affords clinical protection against BVDV type2. Vaccine. 19:2001;3261-3268
30. Hochstein-Mintzel V., Huber H.C., Stickl H. Virulence and immunogenicity of a modified vaccinia virus (strain MVA). Z Immunitätsforsch Exp Klin Immunol. 144:1972;104-156
31. Stickl H., Hochstein-Mintzel V., Mayr A., Huber H.C., Schafer H., Holzner A. MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA). Dtsch Med Wochenschr. 99:1974;2386-2392
32. Hubert P.H., Birkenmaier S., Rziha H.J., Osterrieder N. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. Zentralbl Veterinärmed B. 43:1996;1-14
33. Lobmann M., Charlier P., Florent G., Zygraich N. Clinical evaluation of a temperature-sensitive bovine viral diarrhea vaccine strain. Am. J. Vet. Res. 45:1984;2498-2503
34. Youngner J.S., Whitaker-Dowling P., Chambers T.M., Rushlow K.E., Sebring R. Derivation and characterization of a live attenuated equine influenza vaccine virus. Am. J. Vet. Res. 62:2001;1290-1294
35. Brownlie J., Clarke M.C., Howard C.J. Experimental infection of cattle in early pregnancy with a cytopathic strain of bovine virus diarrhoea virus. Res. Vet. Sci. 46:1989;307-311
36. Kuhn R.J., Griffin D.E., Zhang H., Niesters H.G., Strauss J.H. Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J. Virol. 66:1992;7121-7127
37. Mandl C.W., Holzmann H., Meixner T., Rauscher S., Stadler P.F., Allison S.L. Spontaneous and engineered deletions in the 3′ noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J. Virol. 72:1998;2132-2140
38. Men R., Bray M., Clark D., Chanock R.M., Lai C.J. Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J. Virol. 70:1996;3930-3937
39. Brownlie J., Clarke M.C., Howard C.J., Pocock D.H. Pathogenesis and epidemiology of bovine virus diarrhoea virus infection of cattle. Ann. Rech. Vet. 18:1987;157-166
40. Beer M., Hehnen H.R., Wolfmeyer A., Poll G., Kaaden O.R., Wolf G. A new inactivated BVDV genotype I and II vaccine An immunisation and challenge study with BVDV genotype I. Vet Microbiol. 77:2000;195-208
41. Marshall D.J., Moxley R.A., Kelling C.L. Severe disease following experimental exposure of calves to noncytopathic bovine viral diarrhoea virus isolate New York-1. Aust. Vet. J. 76:1998;428-430
42. Castrucci G., Frigeri F., Osburn B.I., Ferrari M., Sawyer M.M., Aldrovandi V. A study of some pathogenetic aspects of bovine viral diarrhea virus infection. Arch. Virol. Suppl. 3:1991;101-108
43. Devereux J., Haeberli P., Smithies O.A. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acid Res. 12:1984;395